Jonathan J. Darrow
Impact in
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Pharmacology top 5%
- Pharmaceutical industry and healthcare
Papers in
-
- Pharmaceutical Economics and Policy 49
- Health Systems, Economic Evaluations, Quality of Life 44
-
- Pharmaceutical studies and practices 16
- Co-authors
- Aaron S. Kesselheim (52 shared papers)Jerry Avorn (14 shared papers)Jessica M. Franklin (2 shared papers)Thomas J. Hwang (3 shared papers)Bo Wang (1 shared paper)Ameet Sarpatwari (4 shared papers)Reed F. Beall (7 shared papers)Bishal Gyawali (2 shared papers)
- Journals
- The Journal of Law Medicine & Ethics (7 papers)Clinical Pharmacology & Therapeutics (6 papers)New England Journal of Medicine (6 papers)Health Affairs (5 papers)Nature Biotechnology (4 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Jonathan J. Darrow
78 papers receiving 1.5k citations
Jonathan J. Darrow's Hit Papers
Peers
Comparison fields: 5 of 147
- Economics and Econometrics 876
- Pharmacology 148
- Applied Microbiology and Biotechnology 30
- Statistics and Probability 98
- Health Informatics 15
Countries citing papers authored by Jonathan J. Darrow
This map shows the geographic impact of Jonathan J. Darrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Darrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Darrow more than expected).
Fields of papers citing papers by Jonathan J. Darrow
This network shows the impact of papers produced by Jonathan J. Darrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Darrow. The network helps show where Jonathan J. Darrow may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan J. Darrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval and Regulation of Pharmaceuticals, 1983-2018 Hit paper breakdown → | 2020 | 220 |
| 2 | 2019 | 151 | |
| 3 | 2015 | 136 | |
| 4 | 2015 | 88 | |
| 5 | 2014 | 84 | |
| 6 | 2021 | 78 | |
| 7 | 2018 | 72 | |
| 8 | 2017 | 63 | |
| 9 | 2019 | 58 | |
| 10 | 2018 | 41 | |
| 11 | 2018 | 39 | |
| 12 | 2014 | 35 | |
| 13 | 2020 | 33 | |
| 14 | 2018 | 29 | |
| 15 | 2017 | 28 | |
| 16 | 2018 | 25 | |
| 17 | 2018 | 23 | |
| 18 | 2020 | 23 | |
| 19 | 2022 | 17 | |
| 20 | 2013 | 15 |
About Jonathan J. Darrow
Jonathan J. Darrow is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Pharmacology, Physiology and Public Health, Environmental and Occupational Health, having authored 85 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (49 papers), Health Systems, Economic Evaluations, Quality of Life (44 papers), Pharmaceutical studies and practices (16 papers), Pharmaceutical industry and healthcare (15 papers), Biomedical Ethics and Regulation (15 papers), Intellectual Property and Patents (8 papers), Biosimilars and Bioanalytical Methods (8 papers) and Ethics in Clinical Research (5 papers). The work is most often cited by research in Economics and Econometrics (876 citations), Pharmacology (148 citations), Applied Microbiology and Biotechnology (30 citations), Statistics and Probability (98 citations) and Health Informatics (15 citations). Jonathan J. Darrow has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Aaron S. Kesselheim, Jerry Avorn, Jessica M. Franklin, Thomas J. Hwang, Bo Wang, Ameet Sarpatwari, Reed F. Beall, Bishal Gyawali, I. Glenn Cohen and Holly Fernandez Lynch. Their work appears in journals such as The Journal of Law Medicine & Ethics, Clinical Pharmacology & Therapeutics, New England Journal of Medicine, Health Affairs and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.